{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:29:25Z","timestamp":1789144165764,"version":"build-2803163510"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Osteosarcopenia, the coexistence of osteoporosis and sarcopenia, is an emerging and underrecognized complication in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). While muscle and bone loss have been individually observed in MASLD, their combined impact remains poorly addressed in clinical practice. This review outlines the epidemiology, pathophysiological mechanisms, clinical relevance, and current strategies for diagnosing and managing osteosarcopenia in MASLD. Shared pathogenic pathways, including insulin resistance, chronic inflammation, hormonal imbalance, and gut dysbiosis, create a vicious cycle contributing to musculoskeletal degradation and liver disease progression. We highlight the need for proactive screening of osteosarcopenia, and using standardized assessment tools. A multidimensional therapeutic approach, encompassing nutrition, exercise, pharmacotherapy, and emerging metabolic and gut-targeted interventions, may improve not only musculoskeletal health but also hepatic and systemic outcomes. Future studies are warranted to improve long-term prognosis for both osteosarcopenia and MASLD.<\/jats:p>","DOI":"10.3389\/fendo.2025.1706068","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:19:48Z","timestamp":1765430388000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Osteosarcopenia in metabolic dysfunction\u2013associated steatotic liver disease: from mechanisms to management"],"prefix":"10.3389","volume":"16","author":[{"given":"Aili","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clnesp.2020.05.025","article-title":"A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity","volume":"38","author":"Kashiwagi","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.01.045","article-title":"A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older","volume":"42","author":"Kashiwagi","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12877-020-01910\u20133","article-title":"Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Geriatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087517","article-title":"Osteosarcopenia in NAFLD\/MAFLD: an underappreciated clinical problem in chronic liver disease","volume":"24","author":"Musio","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06459-y","article-title":"Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"33","author":"Pan","year":"2022","journal-title":"Osteoporos Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2009.06.004","article-title":"Beyond FRAX: it\u2019s time to consider \u201csarco-osteopenia","volume":"12","author":"Binkley","year":"2009","journal-title":"J Clin Densitom"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02252\u20138","article-title":"Correlation study between bone metabolic markers, bone mineral density, and sarcopenia","volume":"47","author":"Xie","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-015-0494\u20131","article-title":"Osteosarcopenia is more than sarcopenia and osteopenia alone","volume":"28","author":"Drey","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0911","article-title":"Osteosarcopenia and mortality in older adults undergoing transcatheter aortic valve replacement","volume":"9","author":"Solla-Suarez","year":"2024","journal-title":"JAMA Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.10.018","article-title":"Phenotype of osteosarcopenia in older individuals with a history of falling","volume":"16","author":"Huo","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4151\u20138","article-title":"Osteosarcopenia: where bone, muscle, and fat collide","volume":"28","author":"Hirschfeld","year":"2017","journal-title":"Osteoporos Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.09.005","article-title":"The joint occurrence of osteoporosis and sarcopenia (Osteosarcopenia): definitions and characteristics","volume":"21","author":"Sep\u00falveda-Loyola","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05963-x","article-title":"The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls","volume":"32","author":"Teng","year":"2021","journal-title":"Osteoporos Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa755","article-title":"Osteosarcopenia: where osteoporosis and sarcopenia collide","volume":"60","author":"Clynes","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12603-019-1267-x","article-title":"Differences in the prevalence of sarcopenia in community-dwelling, nursing home and hospitalized individuals. A systematic review and meta-analysis","volume":"24","author":"Papadopoulou","year":"2020","journal-title":"J Nutr Health Aging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: Prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024","article-title":"The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis","volume":"12","author":"Meng","year":"2024","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09964\u20131","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Cai","year":"2020","journal-title":"Hepatol Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i8","article-title":"Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease","volume":"14","author":"Almeida","year":"2022","journal-title":"World J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i2.152","article-title":"Metabolic-associated fatty liver disease and sarcopenia: A double whammy","volume":"16","author":"Viswanath","year":"2024","journal-title":"World J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_237_17","article-title":"Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"24","author":"Wijarnpreecha","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1017\/s0007114523000399","article-title":"Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults","volume":"130","author":"Zhou","year":"2023","journal-title":"Br J Nutr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03294\u20133","article-title":"Sarcopenia: imaging assessment and clinical application","volume":"47","author":"Chianca","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1057261","article-title":"Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10439-z","article-title":"Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people","volume":"17","author":"Zhu","year":"2023","journal-title":"Hepatol Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview","volume":"20","author":"Prado","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169465","article-title":"Current status of the diagnosis and management of osteoporosis","volume":"23","author":"Aibar-Almaz\u00e1n","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0528\u20133","article-title":"Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults","volume":"39","author":"Lee","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04038.x","article-title":"Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease","volume":"75","author":"Pirgon","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15087","article-title":"Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density","volume":"49","author":"Mantovani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.825448","article-title":"Prevalence and trends in low bone density, osteopenia and osteoporosis in U.S. Adults with non-alcoholic fatty liver disease, 2005-2014","volume":"12","author":"Zhai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/396545","article-title":"Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease","volume":"2013","author":"Cui","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000000952","article-title":"Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease","volume":"30","author":"Bedimo","year":"2016","journal-title":"Aids"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3380\u20133","article-title":"Total body weight loss of \u2265 10% is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12567","article-title":"Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers","volume":"11","author":"Kirk","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00646\u20136","article-title":"Prevalence of osteosarcopenia and its association with cardiovascular risk factors in Iranian older people: bushehr elderly health (BEH) program","volume":"106","author":"Fahimfar","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jcsm.13392","article-title":"Global epidemiological features and impact of osteosarcopenia: A comprehensive meta-analysis and systematic review","volume":"15","author":"Chen","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-25890-0_11","article-title":"Diagnosis of osteosarcopenia \u2013 clinical","volume-title":"Osteosarcopenia: bone, muscle and fat interactions","author":"Frisoli","year":"2019"},{"key":"B42","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12877-023-04085\u20139","article-title":"Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Geriatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124499","article-title":"Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia: A narrative review","volume":"13","author":"Papadopoulou","year":"2021","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01547-y","article-title":"Prevalence and predictors of osteosarcopenia and relationship with physical functionality in rural and urban Indian women","volume":"20","author":"Bhat","year":"2025","journal-title":"Arch Osteoporos"},{"key":"B45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11657-024-01439\u20137","article-title":"Osteosarcopenia in Finland: prevalence and associated factors","volume":"19","author":"Blomqvist","year":"2024","journal-title":"Arch Osteoporos"},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12877-023-04121\u20138","article-title":"Physical activity and osteosarcopenia in Korean adults aged 65 years and older: a national cross-sectional study using the KNHANES data","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Geriatr"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01968-y","article-title":"Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults","volume":"34","author":"Inoue","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jamda.2023.09.027","article-title":"Associations between osteosarcopenia and falls, fractures, and frailty in older adults: results from the canadian longitudinal study on aging (CLSA)","volume":"25","author":"Lee","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.07.032","article-title":"Osteosarcopenia predicts falls, fractures, and mortality in Chilean community-dwelling older adults","volume":"22","author":"Salech","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly162","article-title":"Does combined osteopenia\/osteoporosis and sarcopenia confer greater risk of falls and fracture than either condition alone in older men? The concord health and ageing in men project","volume":"74","author":"Scott","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052604","article-title":"An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic sarcopenia","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00478.2020","article-title":"Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis","volume":"320","author":"Eriksen","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011\u20133010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4257-z","article-title":"The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011","volume":"29","author":"Ahn","year":"2018","journal-title":"Osteoporos Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1423462","article-title":"Diagnosis and management of cirrhosis-related osteoporosis","volume":"2016","author":"Santos","year":"2016","journal-title":"BioMed Res Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082381","article-title":"Relationship between osteosarcopenia and frailty in patients with chronic liver disease","volume":"9","author":"Saeki","year":"2020","journal-title":"J Clin Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/life11090899","article-title":"Influencing factors and molecular pathogenesis of sarcopenia and osteosarcopenia in chronic liver disease","volume":"11","author":"Saeki","year":"2021","journal-title":"Life (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1283739","article-title":"Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06687-w","article-title":"Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018","volume":"34","author":"Liu","year":"2023","journal-title":"Osteoporos Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06996\u20130","article-title":"Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies","volume":"35","author":"Zeng","year":"2024","journal-title":"Osteoporos Int"},{"key":"B61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00774-023-01488-x","article-title":"Association of chronic liver disease with bone diseases and muscle weakness","volume":"42","author":"Saeki","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e00584","DOI":"10.14309\/ctg.0000000000000584","article-title":"Prevalence of sarcopenia in liver cirrhosis: A systematic review and meta-analysis","volume":"14","author":"Mazeaud","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12891-019-2983\u20134","article-title":"Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis","volume":"20","author":"Saeki","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000001791","article-title":"Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis","volume":"33","author":"Saeki","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-018-4512\u20131","article-title":"Insulin action on protein synthesis and its association with eIF5A expression and hypusination","volume":"46","author":"de Proen\u00e7a","year":"2019","journal-title":"Mol Biol Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00568","article-title":"Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03724\u20134","article-title":"The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD","volume":"85","author":"Pan","year":"2024","journal-title":"Endocrine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030387","article-title":"The management of cardiometabolic risk in MAFLD: therapeutic strategies to modulate deranged metabolism and cholesterol levels","volume":"61","author":"Pezzoli","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023","article-title":"Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0315\u20136","article-title":"Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link","volume":"38","author":"Targher","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1355732","article-title":"Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies","volume":"11","author":"Al Hashmi","year":"2024","journal-title":"Front Nutr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111447","article-title":"Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease","author":"Yodoshi","year":"2021","journal-title":"Nutrition"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: Clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136473","article-title":"Inflammaging-driven osteoporosis: is a galectin-targeted approach needed","volume":"26","author":"Russo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.12168","article-title":"Advances in research on pharmacotherapy of sarcopenia","volume":"4","author":"Feike","year":"2021","journal-title":"Aging Med (Milton)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_68_19","article-title":"Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity","volume":"22","author":"Van de Velde","year":"2020","journal-title":"Asian J Androl"},{"key":"B78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/js.2018\u201300186","article-title":"The anti-inflammatory effects of testosterone","volume":"3","author":"Bianchi","year":"2019","journal-title":"J Endocr Soc"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161402","article-title":"Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.11.010","article-title":"New therapeutic targets for osteoporosis","volume":"120","author":"Anagnostis","year":"2019","journal-title":"Maturitas"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32112\u20133","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2021.1107","article-title":"Skeletal muscle metabolic alternation develops sarcopenia","volume":"13","author":"Yang","year":"2022","journal-title":"Aging Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152359","article-title":"Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update","volume":"11","author":"Jimenez-Gutierrez","year":"2022","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/cia.S170533","article-title":"Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis","volume":"13","author":"Filip","year":"2018","journal-title":"Clin Interv Aging"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e00030","DOI":"10.1097\/in9.0000000000000030","article-title":"Growth hormone and nonalcoholic fatty liver disease","volume":"5","author":"Ma","year":"2023","journal-title":"Immunometabolism (Cobham)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104673","article-title":"Unraveling the metabolic pathways between metabolic-associated fatty liver disease (MAFLD) and sarcopenia","volume":"26","author":"Losasso","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B87","article-title":"The relationship between testosterone and molecular markers of inflammation in older men","volume":"28","author":"Maggio","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","volume":"22","author":"Mohamad","year":"2019","journal-title":"Aging Male"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018\u201300158","article-title":"Reproductive endocrinology of nonalcoholic fatty liver disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.65.303","article-title":"Association between vitamin D status and non-alcoholic fatty liver disease: A population-based study","volume":"65","author":"Liu","year":"2019","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/10408398.2017.1389693","article-title":"Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials","volume":"59","author":"Sharifi","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i6.1718","article-title":"Vitamin D: a new player in non-alcoholic fatty liver disease","volume":"21","author":"Eliades","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/nu9091015","article-title":"Vitamin D supplementation and non-alcoholic fatty liver disease: present and future","volume":"9","author":"Barchetta","year":"2017","journal-title":"Nutrients"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1177\/1178626417703995","article-title":"The role of the growth hormone\/insulin-like growth factor system in visceral adiposity","volume":"10","author":"Lewitt","year":"2017","journal-title":"Biochem Insights"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008\u20131639","article-title":"In vitro and in vivo effects of adiponectin on bone","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156053","article-title":"Evidence from clinical studies of leptin: current and future clinical applications in humans","volume":"161","author":"Perakakis","year":"2024","journal-title":"Metabolism"},{"key":"B97","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/apt.17930","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","author":"Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156056","article-title":"Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone health","volume":"161","author":"Stefanakis","year":"2024","journal-title":"Metabolism"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1038\/s41598-023-31642\u20134","article-title":"Determinants of bone mass in older adults with normal- and overweight derived from the crosstalk with muscle and adipose tissue","volume":"13","author":"Walowski","year":"2023","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-008-0861\u20135","article-title":"The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women","volume":"26","author":"J\u00fcrim\u00e4e","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13127","article-title":"Analysis of the adiponectin paradox in healthy older people","volume":"14","author":"Walowski","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R087510","article-title":"Muscle and adipose tissue insulin resistance: malady without mechanism","volume":"60","author":"Fazakerley","year":"2019","journal-title":"J Lipid Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28946","article-title":"Muscle-bone crosstalk and potential therapies for sarco-osteoporosis","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061899","article-title":"The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review","volume":"12","author":"Gonzalez-Gil","year":"2020","journal-title":"Nutrients"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12686","article-title":"Crosstalk between adipokines and myokines in fat browning","volume":"219","author":"Rodr\u00edguez","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00223-023-01093\u20130","article-title":"Metabolic health and disease: A role of osteokines","volume":"113","author":"Shimonty","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"B108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.10.003","article-title":"Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue","volume":"33","author":"Li","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.7570\/jomes25028","article-title":"Effects of exercise intervention in subjects with metabolic dysfunction-associated steatotic liver disease","volume":"34","author":"Liu","year":"2025","journal-title":"J Obes Metab Syndr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17474124.2019.1569513","article-title":"Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease","volume":"13","author":"Suk","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792098","article-title":"Effect of bone marrow mesenchymal stromal cell therapies in rodent models of sepsis: A meta-analysis","volume":"12","author":"Ge","year":"2021","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017\u2013313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0269\u20139","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.14283\/jfa.2022.59","article-title":"Singapore clinical practice guidelines for sarcopenia: screening, diagnosis, management and prevention","volume":"11","author":"Lim","year":"2022","journal-title":"J Frailty Aging"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-021-1665\u20138","article-title":"International exercise recommendations in older adults (ICFSR): expert consensus guidelines","volume":"25","author":"Izquierdo","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"B122","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00744-w","article-title":"Effects of different types of exercise on bone mineral density in postmenopausal women: A systematic review and meta-analysis","volume":"107","author":"Kemmler","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06682\u20131","article-title":"Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators","volume":"34","author":"Mohebbi","year":"2023","journal-title":"Osteoporos Int"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4862","article-title":"Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: A systematic review and meta-analysis","volume":"38","author":"Su","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.24875\/gmm.24000107","article-title":"Assessment of fracture risk with FRAX and FRAXplus","volume":"160","author":"Tan","year":"2024","journal-title":"Gac Med Mex"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105591","article-title":"Osteosarcopenia: A narrative review on clinical studies","volume":"23","author":"Polito","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jot.2023.09.007","article-title":"Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture","volume":"43","author":"Sheng","year":"2023","journal-title":"J Orthop Translat"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2174\/1570161115666170621080835","article-title":"Lifestyle modifications in non-alcoholic fatty liver disease and non- alcoholic steatohepatitis","volume":"16","author":"Stavropoulos","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051316","article-title":"Beyond body weight-loss: dietary strategies targeting intrahepatic fat in NAFLD","volume":"12","author":"Worm","year":"2020","journal-title":"Nutrients"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101133","article-title":"Dietary pattern modifies the risk of MASLD through metabolomic signature","volume":"6","author":"Wu","year":"2024","journal-title":"JHEP Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.01.005","article-title":"Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease","volume":"122","author":"Armandi","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the american association for the study of liver diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2017.12.003","article-title":"Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: Beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management","author":"Bern\u00e1","year":"2020","journal-title":"Liver Int"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000000986","article-title":"Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis","volume":"29","author":"Hiraoka","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-022-02279\u20136","article-title":"Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group","volume":"34","author":"Chevalley","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12877-024-05009-x","article-title":"Effect of vitamin D, calcium, or combined supplementation on fall prevention: a systematic review and updated network meta-analysis","volume":"24","author":"Tan","year":"2024","journal-title":"BMC Geriatr"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e16855","DOI":"10.7759\/cureus.16855","article-title":"The role of vitamins in non-alcoholic fatty liver disease: A systematic review","volume":"13","author":"Abe","year":"2021","journal-title":"Cureus"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.31083\/ijvnr37275","article-title":"Vitamin K2 alleviates metabolic dysfunction-associated steatotic liver disease through mitochondrial dysfunction modulation via gut microbiota","volume":"95","author":"Wang","year":"2025","journal-title":"Int J Vitam Nutr Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02075\u20137","article-title":"Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism","volume":"59","author":"Cornejo-Pareja","year":"2024","journal-title":"J\u00a0Gastroenterol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bcp.12899","article-title":"The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease","volume":"83","author":"Del Ben","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med Clin North Am"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14774","article-title":"Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications","volume":"24","author":"Vachliotis","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1344376","article-title":"Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe","volume":"15","author":"Chondrogianni","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e220334","DOI":"10.20945\/2359-4292-2022\u20130334","article-title":"Long-term consequences of osteoporosis therapy with bisphosphonates","volume":"68","author":"Gehrke","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179193","article-title":"RANK-RANKL-OPG axis in MASLD: current evidence linking bone and liver diseases and future perspectives","volume":"25","author":"Monti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e15074","DOI":"10.1111\/1756-185x.15074","article-title":"Are bisphosphonates effective in treating osteoporosis in children and adults with cystic fibrosis?-A Cochrane review summary with commentary","volume":"27","author":"Akpinar","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07217-y","article-title":"Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity","volume":"35","author":"Tao","year":"2024","journal-title":"Osteoporos Int"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09107\u20137","article-title":"Sarcopenic obesity and MASLD: A dangerous duo driving deadly cardiometabolic risk","volume":"70","author":"Channapragada","year":"2025","journal-title":"Dig Dis Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155676","article-title":"Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease","volume":"147","author":"Polyzos","year":"2023","journal-title":"Metabolism"},{"key":"B158","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.65044","article-title":"Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies","volume":"18","author":"Fang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2010.10.004","article-title":"MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study","volume":"53","author":"Adunsky","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01037\u20130","article-title":"Liver-specific actions of GH and IGF1 that protect against MASLD","volume":"21","author":"Kineman","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1148934","article-title":"Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100638","article-title":"Emerging therapies for MASLD and their impact on plasma lipids","volume":"17","author":"Nguyen","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol Res"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104\u20139","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1706068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:19:50Z","timestamp":1765430390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1706068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":166,"alternative-id":["10.3389\/fendo.2025.1706068"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1706068","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"article-number":"1706068"}}